Skip to content

Clinical trials

Phase 3 Crohn Disease trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Crohn Disease Phase: Phase 3 Country / region: New Zealand Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20061
20071
20082
20103
20116
20131
20153
20161
20174
20183
20191
20221
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated10
Active, not recruiting3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
GlaxoSmithKline4
Janssen Research & Development, LLC4
Shire3
Genzyme, a Sanofi Company2
Hoffmann-La Roche2
Lakefront Biotherapeutics NV2
Mesoblast, Inc.2
RedHill Biopharma Limited2
UCB Pharma SA2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease33
Inflammatory Bowel Diseases6
Colitis3
Colitis, Ulcerative1
Gastroenteritis1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.